FindTrial
Sign In

iodine I 131

RADIATION4 trials

Sponsors

Lucille P. Markey Cancer Center at University of Kentucky, National Cancer Institute (NCI), Mayo Clinic, University of Washington

Conditions

Head and Neck CancerProstate CancerRecurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid CancerStage IVB Follicular Thyroid CancerStage IVB Papillary Thyroid CancerStage IVC Follicular Thyroid Cancer

Phase 1

Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
CompletedNCT00004062
Lucille P. Markey Cancer Center at University of KentuckyHead and Neck Cancer
Start: 1999-07-31End: 2006-08-31Updated: 2013-12-19
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
TerminatedNCT00788307
Mayo ClinicProstate Cancer
Start: 2008-11-03End: 2018-02-07Updated: 2023-04-18
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
CompletedNCT01413113
University of WashingtonRecurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer +4
Start: 2011-12-31End: 2015-10-31Updated: 2015-11-05

Phase 2

Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
CompletedNCT00085293
National Cancer Institute (NCI)Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer, Stage IVA Papillary Thyroid Cancer +4
Start: 2004-05-31End: 2014-05-31Updated: 2018-11-29

Related Papers

A phase I study of pazopanib in combination with escalating doses of 131I in patients with well-differentiated thyroid carcinoma borderline refractory to radioiodine
PLoS ONE2017-06-2913 citations